ArticleBiomacromolecules2025
Enzyme-Enhanced Manufacturing of Cationized Dialdehyde Cellulose.
Article in Biomacromolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the manufacturing of cellulose derivatives, improving cellulose accessibility is essential for achieving a high product quality. In this study, endoglucanase enzyme treatment was applied prior to the cationization reaction to enhance the accessibility of hydroxyl groups for the production of cationized dialdehyde cellulose (CDAC). A range of enzyme dosages (0.09-45.00 ECU/g) was tested, and their effects on the swelling behavior and surface charge density of the final product were evaluated. The surface charge density of the ultimate cellulosic derivative confirmed its cationization and was proven to enhance the charge density of cationized dialdehyde cellulose (35% increase) compared to untreated pulp with enzyme. Additionally, the modified cellulose exhibited a significantly higher swelling capacity than regular pulps. These findings suggest that enzymatic pretreatment can enhance fiber reactivity and support a more sustainable and efficient production of cellulose-based derivatives, offering a promising potential for commercial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.